Search
forResearch 10 of 1000+
- Estradiol protects hair cells from cisplatin-induced ototoxicity via Nrf2 activation
- Cloning, computational analysis and expression profiling of steroid 5 alpha-reductase 1 (SRD5A1) gene during reproductive phases and ovatide stimulation in endangered catfish, Clarias magur
- Chapter 14 Principles of drug metabolism
- Red ginseng oil promotes hair growth and protects skin against UVC radiation
- Rhamnose-mediated modulation of hair follicle growth: insights from chemical genomics
- Evaluating Antiinflammatory and Antiandrogenic Effects of Garden Cress (Lepidium sativum L.) in HaCaT cells
- Protective Activity against Oxidative Stress in Dermal Papillae with Extracted Herbal Essential Oils
- Baicalin inhibits recruitment of GATA1 to the HSD3B2 promoter and reverses hyperandrogenism of PCOS
- Iron Metabolism of the Skin: Recycling versus Release
- The Opioid Receptor Influences Circadian Rhythms in Human Keratinocytes through the β-Arrestin Pathway
Community 10 of 420
- Phase II topical dut study - outperforms oral fin with a minor DHT reduction
- GT20029 phase II results release date?
- About Pyrilutamide Phase II US Trial
- KX-826 1% Phase II Results from China Just Dropped
- KX-826 Phase II Results Just Dropped (Male AGA) – Key Takeaways
- GT20029 - Promising phase II results
- GT20029 China Phase II Trial For AGA Reached Primary Endpoint
- Where are GT20029 phase II results?
- Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China
- So why did the first pyrilutamide phase III fail?
Learn
— no results
Try a deeper search in learn →